PeptideLabs Logo
PeptideLabs
Documentación de Calidad
Back to all 64 profiles
Community/research information onlyNo aprobado por FDA/EMA

Community protocol · AHK-Cu

AHK-Cu: community information and evidence, clearly separated.

A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.

Also known as: Copper tripeptide AHK · Alanine-Histidine-Lysine copper

Sources checked: 27 August 2026

Aviso importante de seguridad y responsabilidad

Esta página documenta y evalúa información de comunidades. No es consejo médico ni terapéutico, asesoramiento individual ni invitación al uso.

No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.

Quick context

AHK-Cu

Se comenta principalmente en modelos cosméticos de piel y cabello; el beneficio y la seguridad medicinales no están confirmados.

No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.

Amounts, timing and cycles

Community/research information only

No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.

Amount status

Different amounts circulate online; no regulator-confirmed safe or effective dose exists.

Profile evidence level: preclinical.

Timing

Community claims about time of day, fasting windows or training intervals are not validated clinical standards.

No individual recommendation.

Cycle/duration

Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.

No individual recommendation.

No matching detail page found in the reference source

The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.

Reconstitución y conversión U-100

No generic calculator

Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.

Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.

Mechanism and research questions

Copper-binding tripeptide studied in skin and hair models

AHK-Cu is classified as “Copper-binding tripeptide studied in skin and hair models”. Se comenta principalmente en modelos cosméticos de piel y cabello; el beneficio y la seguridad medicinales no están confirmados. This describes the investigated pathway but does not validate a community use, amount, route or combination.

01

Tripéptido que une cobre

Esto estudia cómo un péptido corto une iones de cobre y podría apoyar la señalización celular en el tejido de la piel, de forma similar a un contenedor de transporte para un oligoelemento importante. Se miden marcadores de colágeno y actividad celular en modelos de piel.

02

Señalización de la matriz cutánea

Esto examina cómo las señales afectan al colágeno y otras proteínas estructurales que dan firmeza y elasticidad a la piel, de forma similar a estudiar el andamiaje bajo la superficie de un edificio. Los investigadores suelen medir la producción de colágeno y la estructura de la piel en modelos cutáneos de laboratorio.

03

Péptido de migración celular

Esto estudia cómo un péptido influye en la migración de las células hacia un sitio de lesión, de forma similar a los trabajadores que se apresuran a una obra. Se miden la velocidad y el alcance de la migración celular en modelos de laboratorio.

What communities discuss

These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.

Anécdotas de piel y cabello

Los usuarios intercambian impresiones personales sobre la apariencia de la piel, la profundidad de las arrugas o el crecimiento del cabello tras usar péptidos comercializados cosméticamente, generalmente basándose en sus propias fotos en lugar de dispositivos de medición. Estas impresiones subjetivas y afirmaciones de marketing no son prueba de un efecto confirmado.

Afirmaciones de marketing de proveedores

Los proveedores a menudo publicitan productos con amplias afirmaciones de eficacia, tablas comparativas frente a la competencia y citas de clientes. Estas declaraciones de marketing están impulsadas por el interés de venta y no constituyen una prueba científica independiente de eficacia.

Discusión de origen y pureza

Se discute qué proveedores se consideran más confiables y cómo difieren los resultados de las pruebas de pureza entre lotes. Estas evaluaciones comunitarias se basan en muestras limitadas y no reemplazan las pruebas de laboratorio independientes de cada lote individual.

Adverse effects and risk boundaries

  • Las sustancias tópicas pueden irritar, sensibilizar o causar alergia de contacto; la inyección o una forma incierta aumentan mucho los riesgos sistémicos, de esterilidad y contaminación.
  • Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
  • A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Exclusion groups and professional assessment

  • Piel abierta o infectada, alergias conocidas, embarazo y cambios cutáneos inexplicados deben valorarse antes de uso cosmético o médico.
  • Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
  • Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

  • La reacción cutánea, el área/concentración documentada y suspender ante irritación son más relevantes que analíticas; el uso sistémico requiere otra evaluación.
  • Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

Preclínico

Aún no se ha establecido un beneficio médico confirmado.

Published evidence

Los datos disponibles provienen principalmente de modelos animales o celulares; faltan datos sólidos de eficacia y seguridad en humanos.

El AHK-Cu se estudia principalmente en modelos cosméticos de cabello y piel, mientras que el GHK-Cu se investiga de forma más amplia en torno a la matriz cutánea y la señalización del colágeno.

Storage and stability

  • The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
  • Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
  • Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.

Troubleshooting and error sources

  • U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
  • Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
  • Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
  • Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

No aprobado por FDA/EMA

No existe medicamento aprobado por FDA o EMA; eficacia y seguridad no están establecidas.

WADA 2026

The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.

WADA — 2026 Prohibited List

Combinations / stacks

  • Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
  • Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
  • Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.